Skip to main content
SpringerLink
Log in

The Pathophysiology and Pathology of Intrahepatic and Extrahepatic Cholangiocarcinomas

  • Reference work entry
  • First Online:
Hepato-Pancreato-Biliary Malignancies

  • 666 Accesses

Abstract

Cholangiocarcinomas are primary adenocarcinomas with biliary differentiation that can be further subdivided into intrahepatic and extrahepatic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 329.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WHO Classification of Tumours Editorial Board. Digestive system tumours. Lyon: International Agency for Research on Cancer; 2019. p. 254–9.

    Google Scholar 

  2. Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–89.

    Article  Google Scholar 

  3. Torbenson MS. Biopsy interpretation of the liver. Philadelphia: Wolters Kluwer Health; 2015.

    Google Scholar 

  4. Saxena R. Practical hepatic pathology: a diagnostic approach. 2nd ed. Philadelphia: Elsevier; 2018. 34: Benign and Malignant Tumors of Bile Ducts; 545–554.

    Google Scholar 

  5. Zhang H, Yang T, Wu M, Shen F. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett. 2016;379(2):198–205.

    Article  CAS  Google Scholar 

  6. Krasinskas AM. Cholangiocarcinoma. Surg Pathol Clin. 2018;11(2):403–29.

    Article  Google Scholar 

  7. Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729245.

    Article  Google Scholar 

  8. Buettner S, van Vugt JL, IJzermans JN, Koerkamp BG. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther. 2017;10:1131.

    Article  CAS  Google Scholar 

  9. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, Cho HJ, Kim KA, Choi SY. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29(3):683–700.

    Article  Google Scholar 

  10. Kozaka K, Sasaki M, Fujii T, et al. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘bile ductular carcinoma’. Histopathology. 2007;51(3):390–400.

    Article  CAS  Google Scholar 

  11. Lau SK, Prakash S, Geller SA, Alsabeh R. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol. 2002;33(12):1175–81.

    Article  Google Scholar 

  12. Rullier A, Le Bail B, Fawaz R, et al. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol. 2000;24(6):870–6.

    Article  CAS  Google Scholar 

  13. Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122(9):1349–69.

    Article  Google Scholar 

  14. Rahnemai-Azar AA, Weisbrod A, Dillhoff M, Schmidt C, Pawlik TM. Intrahepatic cholangiocarcinoma: molecular markers for diagnosis and prognosis. Surg Oncol. 2017;26(2):125–37.

    Article  Google Scholar 

  15. McKay SC, Unger K, Pericleous S, Stamp G, Thomas G, Hutchins RR, Spalding DR. Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma. HPB. 2011;13(5):309–19.

    Article  Google Scholar 

  16. Chun YS, Pawlik TM, Vauthey JN. 8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25(4):845–7.

    Article  Google Scholar 

  17. Aloia T, Pawlik T, Taouli B, Rubbia-Brandt L, Vauthey JN. Intrahepatic bile ducts. In: 8th ed. AJCC cancer staging manual. Springer International Publishing; 2017. p. 295–302.

    Chapter  Google Scholar 

  18. Moeini A, Sia D, Bardeesy N, Mazzaferro V, Llovet JM. Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma. Clin Cancer Res. 2016;22(2):291–300.

    Article  Google Scholar 

  19. WHO classification of tumours editorial board: tumours of the gallbladder and extrahepatic bile ducts. In: WHO classification of tumours: digestive system tumours. 5th ed. Lyon: IARC Press; 2019. p. 289–91.

    Google Scholar 

  20. Roos E, Franken LC, Soer EC, van Hooft JE, Takkenberg RB, Klümpen HJ, Wilmink JW, van de Vijver MJ, van Gulik TM, Verheij J. Lost in translation: confusion on resection and dissection planes hampers the interpretation of pathology reports for perihilar cholangiocarcinoma. Virchows Arch. 2019;475(4):435–43.

    Article  Google Scholar 

  21. Jarnagin WR. Cholangiocarcinoma of the extrahepatic bile ducts. In Seminars in surgical oncology 2000 Sep (Vol. 19, No. 2, pp. 156–176). New York: Wiley.

    Google Scholar 

  22. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. In: Seminars in liver disease 2004 May (Vol. 24, No. 02, pp. 115–125). New York: Copyright© 2004 by Thieme Medical Publishers, Inc.

    Google Scholar 

  23. Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra-and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98(12):873–5.

    Article  Google Scholar 

  24. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts, and vaterian system. American Registry of Pathology; 2015.

    Book  Google Scholar 

  25. Funabiki T, Matsubara T, Miyakawa S, Ishihara S. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbeck’s Arch Surg. 2009;394(1):159–69.

    Article  Google Scholar 

  26. Rabinovitz M, Zajko AB, Hassanein T, Shetty B, Bron KM, Schade RR, Gavaler JS, Block G, van Thiel DH, Dekker A. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology. 1990;12(4):747–52.

    Article  CAS  Google Scholar 

  27. Higuchi R, Yazawa T, Uemura S, Izumo W, Furukawa T, Yamamoto M. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study. J Hepatobiliary Pancreat Sci. 2017;24(8):456–65.

    Article  Google Scholar 

  28. Nagorney DM, Pawlik TM, Chun YS, Ebata T, Vauthey JN. Perihilar bile ducts. In: 8th ed. AJCC cancer staging manual. Springer International Publishing; 2017. p. 311–6.

    Chapter  Google Scholar 

  29. Krasinskas A, Pawlik TM, Kenudson MM, Vauthey JN. Distal bile ducts. In: 8th ed. AJCC cancer staging manual. Springer International Publishing; 2017. p. 317–26.

    Chapter  Google Scholar 

  30. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, et al., editors. AJCC cancer staging manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017. [cited 2016 Dec 28]. p. 295–302.

    Google Scholar 

  31. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, et al., editors. AJCC cancer staging manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017. [cited 2016 Dec 28]. p. 311–6.

    Google Scholar 

  32. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, et al., editors. AJCC cancer staging manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017. [cited 2016 Dec 28]. p. 317–25.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Chicago, Chicago, IL, USA

    Cindy Wang & Namrata Setia

Authors
  1. Cindy Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Namrata Setia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Namrata Setia .

Editor information

Editors and Affiliations

  1. Medical Director, Capital Health Cancer Center, Director, CH Pancreas Center of Excellence, Director, CH Liver Center of Excellence, Pennington, NJ, USA

    Cataldo Doria

  2. Director of Interventional Gastroenterology, Capital Health Medical Center, Pennington, NJ, USA

    Jason N. Rogart

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Wang, C., Setia, N. (2022). The Pathophysiology and Pathology of Intrahepatic and Extrahepatic Cholangiocarcinomas. In: Doria, C., Rogart, J.N. (eds) Hepato-Pancreato-Biliary Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-030-41683-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41683-6_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-41682-9

  • Online ISBN: 978-3-030-41683-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation